ARTIVION, INC. (AORT) Executive Compensation
ARTIVION, INC. (AORT) is a publicly traded company on the NYSE, categorized under SIC 3841 (Surgical & Medical Instruments & Apparatus). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: AORT
CIK: 784199
Exchange: NYSE
SIC 3841: Surgical & Medical Instruments & Apparatus
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerPramit Mehta
Audit LocationAtlanta, Georgia, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-11 | 2026-09-10 | FORM 4 | 0001628280-26-061602 | View SEC Doc Filr Page |
| 144 | 2026-09-10 | — | 144 Filing | 0001959173-26-006850 | View SEC Doc Filr Page |
| 4 | 2026-09-04 | 2026-09-02 | FORM 4 | 0001628280-26-060667 | View SEC Doc Filr Page |
| 144 | 2026-09-03 | — | 144 Filing | 0001959173-26-006726 | View SEC Doc Filr Page |
| 144 | 2026-09-02 | — | 144 Filing | 0001959173-26-006673 | View SEC Doc Filr Page |
| 144 | 2026-08-27 | — | 144 Filing | 0001959173-26-006490 | View SEC Doc Filr Page |
| 4 | 2026-08-20 | 2026-08-19 | FORM 4 | 0001628280-26-058212 | View SEC Doc Filr Page |
| 144 | 2026-08-19 | — | 144 Filing | 0001959173-26-006228 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-14 | FORM 4 | 0001628280-26-057330 | View SEC Doc Filr Page |
| 4 | 2026-08-17 | 2026-08-14 | FORM 4 | 0001628280-26-057327 | View SEC Doc Filr Page |
| 144 | 2026-08-14 | — | 144 Filing | 0001959173-26-006039 | View SEC Doc Filr Page |
| 144 | 2026-08-14 | — | 144 Filing | 0001959173-26-006035 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000905148-26-003678 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-12 | FORM 4 | 0001628280-26-056381 | View SEC Doc Filr Page |
| 10-Q | 2026-08-07 | 2026-06-30 | 10-Q | 0001628280-26-054746 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001628280-26-054294 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-06 | — | SCHEDULE 13G/A Filing | 0000315066-26-001921 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | FORM 4 | 0001628280-26-043059 | View SEC Doc Filr Page |
| 144 | 2026-06-11 | — | 144 Filing | 0001959173-26-004573 | View SEC Doc Filr Page |
| 3 | 2026-06-08 | 2026-06-01 | FORM 3 | 0001628280-26-041704 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-02 | FORM 4 | 0001628280-26-040860 | View SEC Doc Filr Page |
| SD | 2026-05-21 | — | SD | 0001628280-26-037127 | View SEC Doc Filr Page |
| 4/A | 2026-05-20 | 2026-05-18 | FORM 4/A | 0001628280-26-037028 | View SEC Doc Filr Page |
| 4 | 2026-05-20 | 2026-05-18 | FORM 4 | 0001628280-26-037008 | View SEC Doc Filr Page |
| 4 | 2026-05-20 | 2026-05-18 | FORM 4 | 0001628280-26-037006 | View SEC Doc Filr Page |